Who are Pregabalin 25 MG's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Neurontin, Magnesium Sulfate, Pregabalin capsule, Gabapentin Enacarbil (GEn), Magnesium Sulfate Infusion, Depakote DR.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/pregabalin-25-mg.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Pregabalin 25 MG — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pregabalin 25 MG (Pregabalin 25 MG) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticonvulsant. Area: Neuroscience.

marketed Anticonvulsant α2δ subunit of voltage-gated calcium channels Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Pregabalin 25 MG (Pregabalin 25 MG) — Ajou University School of Medicine.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Pregabalin 25 MG TARGET	Pregabalin 25 MG	Ajou University School of Medicine	marketed	Anticonvulsant	α2δ subunit of voltage-gated calcium channels
Neurontin	gabapentin	Generic (originally Parke-Davis/Pfizer)	marketed	Gabapentinoid (anticonvulsant/neuropathic pain agent)	Large neutral amino acids transporter small subunit 1, Adenosine receptor A1, Alpha-2A adrenergic receptor	1993-12-30
Magnesium Sulfate	Magnesium Sulfate	Pfizer	marketed	Electrolyte; anticonvulsant	Neuromuscular junction; motor nerve impulse; acetylcholine release	1981-01-01
Pregabalin capsule	Pregabalin capsule	Guang'anmen Hospital of China Academy of Chinese Medical Sciences	marketed	Gabapentinoid; anticonvulsant; anxiolytic	Alpha-2-delta subunit of voltage-gated calcium channels
Gabapentin Enacarbil (GEn)	Gabapentin Enacarbil (GEn)	Cleveland Sleep Research Center	marketed	Gabapentinoid; anticonvulsant/neuropathic pain agent	Voltage-gated calcium channel alpha-2-delta subunit
Magnesium Sulfate Infusion	Magnesium Sulfate Infusion	Ondokuz Mayıs University	marketed	Electrolyte supplement / anticonvulsant / tocolytic agent	NMDA receptor antagonist; calcium channel modulator
Depakote DR	Depakote DR	Massachusetts General Hospital	marketed	Anticonvulsant; mood stabilizer; histone deacetylase inhibitor	GABA synthesis/metabolism; histone deacetylase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticonvulsant class)

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · 2 drugs in this class
Ajou University School of Medicine · 1 drug in this class
CAMC Health System · 1 drug in this class
GlaxoSmithKline · 1 drug in this class
Hospital Universitari de Bellvitge · 1 drug in this class
Pfizer Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Pregabalin 25 MG — Competitive Intelligence Brief. https://druglandscape.com/ci/pregabalin-25-mg. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing